The LCLAT1/LYCAT acyltransferase is required for EGF-mediated phosphatidylinositol-3,4,5-trisphosphate generation and Akt signalling

Victoria Chan,Cristina Camardi,Kai Zhang,Laura Orofiamma,Karen E. Anderson,Jafarul Hoque,Leslie Bone,Yasmin Awadeh,Daniel K.C. Lee,Norman J. Fu,Jonathan T.S. Chow,Leonardo Salmena,Len R. Stephens,Phillip T Hawkins,Costin N. Antonescu,Roberto J. Botelho

DOI: https://doi.org/10.1101/2023.01.26.524308

2024-06-26

Abstract:Receptor tyrosine kinases such as epidermal growth factor receptor (EGFR) stimulate phosphoinositide 3-kinases (PI3Ks) to convert phosphatidylinositol-4,5-bisphosophate [PtdIns(4,5)P2] into phosphatidylinositol-3,4,5-trisphosphate [PtdIns(3,4,5)P3]. PtdIns(3,4,5)P3 then remodels actin and gene expression, and boosts cell survival and proliferation. PtdIns(3,4,5)P3 partly achieves these functions by triggering activation of the kinase Akt, which phosphorylates targets like Tsc2 and GSK3β. Consequently, unchecked upregulation of PtdIns(3,4,5)P3-Akt signalling promotes tumour progression. Interestingly, 50-70% of PtdIns and PtdInsPs have stearate and arachidonate at sn-1 and sn-2 positions of glycerol, respectively, forming a species known as 38:4-PtdIns/PtdInsPs. LCLAT1 and MBOAT7 acyltransferases partly enrich PtdIns in this acyl format. We previously showed that disruption of LCLAT1 lowered PtdIns(4,5)P2 levels and perturbed endocytosis and endocytic trafficking. However, the role of LCLAT1 in receptor tyrosine kinase and PtdIns(3,4,5)P3 signaling was not explored. Here, we show that LCLAT1 silencing in MDA-MB-231 and ARPE-19 cells abated the levels of PtdIns(3,4,5)P3 in response to EGF signalling. Importantly, LCLAT1-silenced cells were also impaired for EGF-driven and insulin-driven Akt activation and downstream signalling. Thus, our work provides first evidence that the LCLAT1 acyltransferase is required for receptor tyrosine kinase signalling.

Cell Biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the role of LCLAT1 acyltransferase in epidermal growth factor (EGF)-mediated phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) production and the Akt signaling pathway. Specifically, researchers have found that LCLAT1 plays an important role in regulating PtdIns(4,5)P2 levels as well as in endocytosis and endocytic transport, but its role in receptor tyrosine kinase (such as EGFR) and PtdIns(3,4,5)P3 signaling has not yet been explored. Therefore, the paper aims to investigate the impact of silencing the LCLAT1 gene on EGF signaling, particularly the production of PtdIns(3,4,5)P3 and the activation of Akt. The study results indicate that LCLAT1 is crucial for receptor tyrosine kinase signaling.